Company Quick10K Filing
Cellular Biomedicine Group
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-12-07 Regulation FD, Other Events, Exhibits
8-K 2019-11-11
8-K 2019-11-11 Regulation FD, Exhibits
8-K 2019-11-08 Regulation FD, Exhibits
8-K 2019-10-01 Enter Agreement, Other Events, Exhibits
8-K 2019-09-27 Regulation FD, Exhibits
8-K 2019-09-12 Regulation FD, Exhibits
8-K 2019-09-11 Regulation FD, Exhibits
8-K 2019-08-27 Enter Agreement, Exhibits
8-K 2019-07-23 Regulation FD, Exhibits
8-K 2019-06-17 Regulation FD, Exhibits
8-K 2019-05-15
8-K 2019-04-26 Shareholder Vote, Regulation FD, Exhibits
8-K 2019-04-25 Regulation FD, Exhibits
8-K 2019-04-23 Regulation FD, Exhibits
8-K 2019-03-28 Regulation FD, Exhibits
8-K 2019-03-21 Enter Agreement, Other Events, Exhibits
8-K 2019-03-20 Regulation FD, Exhibits
8-K 2019-03-01 Regulation FD, Exhibits
8-K 2019-01-19 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2019-01-19 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2019-01-17 Regulation FD, Exhibits
8-K 2019-01-08 Regulation FD, Exhibits
8-K 2018-12-31 Other Events
8-K 2018-12-21 Enter Agreement, Exhibits
8-K 2018-11-07 Other Events
8-K 2018-10-29 Regulation FD, Exhibits
8-K 2018-10-10 Other Events
8-K 2018-10-02 Enter Agreement, Other Events, Exhibits
8-K 2018-10-02 Regulation FD, Exhibits
8-K 2018-09-25 Enter Agreement, Sale of Shares, Other Events, Exhibits
8-K 2018-06-22 Regulation FD, Exhibits
8-K 2018-04-27 Shareholder Vote, Regulation FD, Exhibits
8-K 2018-04-23 Other Events
8-K 2018-04-19 Other Events
8-K 2018-03-16 Regulation FD, Exhibits
8-K 2018-03-06 Earnings, Exhibits
8-K 2018-02-15 Other Events
8-K 2018-02-06 Officers
8-K 2018-02-05 Enter Agreement, Sale of Shares, Officers, Other Events, Exhibits
8-K 2018-01-30 Enter Agreement, Sale of Shares, Exhibits

Cellular Biomedicine Group Financials

-

CBMG Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Arsanis (ASNS) 29,581 133,507 37,339 3,500 0 -22,768 -21,230 -39,343
Cidara Therapeutics (CDTX) 44,703 51,752 19,970 0 0 -56,069 -55,651 130
Xtant Medical Holdings (XTNT) 32,125 44,497 85,573 67,526 39,499 -64,228 -53,862 98,746
Ampliphi Biosciences (APHB) 2,988 34,916 12,286 0 0 -13,742 -13,208 -10,904
Protalix Biotherapeutics (PLX) 55,242 122,727 663 -1,254 -20,770 -16,381 -25,096
Organovo Holdings (ONVO) 57,323 43,451 7,312 3,070 2,608 -25,542 -24,645 21,757
Neuralstem (CUR) 311 3,522 1,559 0 0 -6,702 -6,545 -1,971
Vical (VICL) 19,415 42,701 1,159 171 0 -12,124 -12,004 8,602
Tracon Pharmaceuticals (TCON) 23,950 27,951 19,032 0 0 -30,380 -30,353 4,614
Cytrx (CYTR) 11,100 19,942 1,855 250 0 -8,329 -7,551 -8,277
Aevi Genomic Medicine (GNMX) 11,658 4,021 3,689 0 0 -22,359 -22,359 8,221
Vaxart (VXRT) 11,208 37,250 21,405 7,455 0 -18,426 -13,768 -5,092
Trovagene (TROV) 13,984 13,868 5,020 467 440 -15,958 -15,494 3,193
Titan Pharmaceuticals (TTNP) 18,683 6,761 7,332 3,832 3,060 -15,263 -14,984 20,422
Proteon Therapeutics (PRTO) 8,030 11,600 2,123 0 0 -21,615 -21,615 -2,805
Microbot Medical (MBOT) 3,317 12,575 4,594 0 0 -7,381 -7,381 -5,812
Biondvax Pharmaceuticals (BVXV) 0 105,837 0 0 0 0 -707
Cellular Biomedicine Group (CBMG) 190,535 117,687 35,510 145 78 -42,696 -38,564 133,821
Aptose Biosciences (APTO) 38,190 4,434 0 0 -17,985 -17,903 -26,898
Asterias Biotherapeutics (AST) 29,814 5,309 731 540 -20,296 -18,593 -6,524

Balance Sheet ($'000)2011-12-312012-03-312012-09-302012-12-312013-03-312013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash60331507574,8533,4657,1755,95713,5649,81614,77131,14523,65120,10614,88515,66847,47044,11639,25233,36227,29816,29221,56845,55624,78657,92552,81362,03856,714
Accounts Receivable2,647001135241751413404454116305833315340809114520312913438100
Inventory39401191341563483722784004223914863142530
PP&E1,4081,8761,8991,9011,9592,8503,0243,2753,3673,8194,9555,1505,7595,5646,6767,18410,08314,45016,81519,29519,37520,25722,05723,12027,955
Assets1,5451,3256,7375,29415,61916,50117,59717,77126,20741,57443,68557,93967,05561,87749,46071,30287,54172,73468,62863,59159,87753,62761,16286,72675,815106,41591,643121,339117,687
Accounts Payable189602131771161572141771092244271601071462612091362202167821,1691,2362253323884844238691,352
Long-Term Debt
Liabilities1,9711,8894,5542,4953,0461,8862,2021,8192,5205,3184,5295,2715,4584,9513,0956,5822,5131,9402,7352,3684,5203,8623,8605,4044,8836,3726,42528,82835,510
Stockholders' Equity-426-5652,1832,79912,57314,61515,39515,95223,68736,25639,15652,66861,59656,92646,36564,72185,02870,79465,89461,22355,35749,76457,30381,32270,932100,04385,21892,51182,177
Income Statement ($'000)2011-12-312012-03-312012-09-302012-12-312013-03-312013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue5,88703,1881,6981180385603657625620488721058981511076951777026490
Cost of Revenue00158545253154372280
Gross Profit05,88703,03076333723334410
R&D4811975744989447387937341,3232,1902,6052,3982,9732,8983,2073,0443,4964,0764,1405,2747,3646,5456,1645,9689,063
SG&A2263235,1011,8459931,4141,7632,0433,4843,5853,9303,6573,3612,9553,1122,9143,1143,3033,7903,1093,3343,2633,3803,4003,6513,4903,222
Tax000386-420000152-236994886243-92002207021
Net Income-2445,164-5,844577-6,453-447-6,674-2,823-5,531-4,287-5,026-5,142-4,992-4,210-7,197-10,661-6,140-6,162-1,704-6,202-6,923-8,496-9,186-12,744-8,519-9,337-12,097
Cash Flow ($'000)2011-12-312012-03-312012-09-302012-12-312013-03-312013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-261-1,824-1,329-2,379-2,343-3,404-2,173-2,406-3,294-2,872-3,179-3,583-5,170-3,320-3,795-4,859-2,919-6,174-4,642-5,612-8,044-5,703-5,754-7,905-10,746
Cash Investing2,535-2,576-19-58-244-1,484-748-3,862-885-2,208-675-487-492-1,080-1,050-1,987-3,965-3,191-1,083-11,119-2,2707,862-4,164-4,057
Cash Financing-27-17,5931,18910,000-1008,60019,591-3922442045,06337,5505101626-1,290-92613,03730,563-1,42741,420-7,44121,2109,469